Journal ArticleOPEN ACCESS

Risk of malignancy in 22q11.2 deletion syndrome

  • Stevens T
  • van der Werff ten Bosch J
  • De Rademaeker M
  • et al.
Clinical Case Reports (2017) 5(4) 486-490
DOI: 10.1002/ccr3.880
N/ACitations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

22q11.2 DS is a significant health problem because of its fairly high incidence. It is relevant to be vigilant regarding the diagnosis of cancer amongst 22q11.2 patients as there might be an increased risk, especially amongst patients with the 22q11.2 distal deletion syndrome.

Cite

CITATION STYLE

APA

Stevens, T., van der Werff ten Bosch, J., De Rademaeker, M., Van Den Bogaert, A., & van den Akker, M. (2017). Risk of malignancy in 22q11.2 deletion syndrome. Clinical Case Reports, 5(4), 486–490. https://doi.org/10.1002/ccr3.880

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free